Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lobmaier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Addiction (Abingdon, England)|March 21, 2016
Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxonePhilipp P Lobmaier, Thomas Clausen
Health & Justice|March 16, 2020
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participationJordan M Hyatt, Philipp P Lobmaier
Drug and Alcohol Dependence|September 27, 2016
Removal notice to "Sustained-release naltrexone for opioid dependence: A cochrane review and meta-analysis" [Drug Alcohol Depend. 146 (2015) e165-e166]Nikolaj Kunøe, Philipp P Lobmaier, H Kornør
The Cochrane Database of Systematic Reviews|April 22, 2008
Sustained-release naltrexone for opioid dependenceP Lobmaier, H Kornør, N Kunøe, et al.
CNS Neuroscience & Therapeutics|May 11, 2011
Naltrexone depot formulations for opioid and alcohol dependence: a systematic reviewPhilipp P Lobmaier, Nikolaj Kunøe, Michael Gossop, et al.
European Addiction Research|April 29, 2010
Naltrexone implants compared to methadone: outcomes six months after prison releasePhilipp P Lobmaier, Nikolaj Kunøe, Michael Gossop, et al.
Journal of Analytical Toxicology|June 12, 2008
Drug screening of hair by liquid chromatography-tandem mass spectrometryS Hegstad, H Z Khiabani, L Kristoffersen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 2019
Intact responses to non-drug rewards in long-term opioid maintenance treatmentMarie Eikemo, Philipp P Lobmaier, Mads L Pedersen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Addiction (Abingdon, England)|March 21, 2016
Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxonePhilipp P Lobmaier, Thomas Clausen
Health & Justice|March 16, 2020
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participationJordan M Hyatt, Philipp P Lobmaier
Drug and Alcohol Dependence|September 27, 2016
Removal notice to "Sustained-release naltrexone for opioid dependence: A cochrane review and meta-analysis" [Drug Alcohol Depend. 146 (2015) e165-e166]Nikolaj Kunøe, Philipp P Lobmaier, H Kornør
The Cochrane Database of Systematic Reviews|April 22, 2008
Sustained-release naltrexone for opioid dependenceP Lobmaier, H Kornør, N Kunøe, et al.
CNS Neuroscience & Therapeutics|May 11, 2011
Naltrexone depot formulations for opioid and alcohol dependence: a systematic reviewPhilipp P Lobmaier, Nikolaj Kunøe, Michael Gossop, et al.
European Addiction Research|April 29, 2010
Naltrexone implants compared to methadone: outcomes six months after prison releasePhilipp P Lobmaier, Nikolaj Kunøe, Michael Gossop, et al.
Journal of Analytical Toxicology|June 12, 2008
Drug screening of hair by liquid chromatography-tandem mass spectrometryS Hegstad, H Z Khiabani, L Kristoffersen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 2019
Intact responses to non-drug rewards in long-term opioid maintenance treatmentMarie Eikemo, Philipp P Lobmaier, Mads L Pedersen, et al.
Pageof 1